rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1995-6-8
|
pubmed:abstractText |
To evaluate the influence of a H2 receptor antagonist (cimetidine) on survival in patients with colorectal carcinoma, a randomized, controlled pilot study was performed in three university hospitals in Copenhagen, Denmark.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0012-3706
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
514-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7736883-Adenocarcinoma,
pubmed-meshheading:7736883-Adult,
pubmed-meshheading:7736883-Aged,
pubmed-meshheading:7736883-Aged, 80 and over,
pubmed-meshheading:7736883-Chemotherapy, Adjuvant,
pubmed-meshheading:7736883-Cimetidine,
pubmed-meshheading:7736883-Colonic Neoplasms,
pubmed-meshheading:7736883-Denmark,
pubmed-meshheading:7736883-Double-Blind Method,
pubmed-meshheading:7736883-Female,
pubmed-meshheading:7736883-Follow-Up Studies,
pubmed-meshheading:7736883-Humans,
pubmed-meshheading:7736883-Male,
pubmed-meshheading:7736883-Middle Aged,
pubmed-meshheading:7736883-Pilot Projects,
pubmed-meshheading:7736883-Placebos,
pubmed-meshheading:7736883-Rectal Neoplasms,
pubmed-meshheading:7736883-Survival Rate,
pubmed-meshheading:7736883-Treatment Outcome
|
pubmed:year |
1995
|
pubmed:articleTitle |
Cimetidine as an adjuvant treatment in colorectal cancer. A double-blind, randomized pilot study.
|
pubmed:affiliation |
Department of Gastrointestinal Surgery, University of Copenhagen, Denmark.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|